Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

apnews.com/article/zepbound-wegovy-weight-loss-drugs-2df62bb4f1270bdfbeed61b7661f535e

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.
Clinical trial…

This story appeared on apnews.com, 2025-05-11 23:55:23.338000.
The Entire Business World on a Single Page. Free to Use →